Supernus Pharmaceuticals | SUPN - Le Chiffre D'Affaires De Vente





Ventes Changement Date
Abbott USD 12.59B 1.43B 2026-06
ANI Pharmaceuticals USD 266M 28.5M 2026-06
Aurora Cannabis CAD 38.01M 56.18M 2026-03
Bristol-Myers Squibb USD 12.97B 1.48B 2026-06
Canopy Growth CAD 71.25M 3.29M 2026-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Corcept Therapeutics USD 256.15M 91.25M 2026-06
Eisai JPY 234.33B 28.9B 2026-06
Eli Lilly USD 22.97B 3.17B 2026-06
Novo Nordisk DKK 78.49B 18.33B 2026-06
Pacira USD 192.4M 15.4M 2026-06
Perrigo USD 1.02B 51M 2026-06
Pfizer USD 15.03B 530M 2026-06
Supernus Pharmaceuticals USD 219.1M 11.39M 2026-06
United Therapeutics USD 783.3M 1.8M 2026-06
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03